WO2006048266A3 - Profil d'expression genetique de leucemies a rearrangements geniques mll - Google Patents

Profil d'expression genetique de leucemies a rearrangements geniques mll Download PDF

Info

Publication number
WO2006048266A3
WO2006048266A3 PCT/EP2005/011732 EP2005011732W WO2006048266A3 WO 2006048266 A3 WO2006048266 A3 WO 2006048266A3 EP 2005011732 W EP2005011732 W EP 2005011732W WO 2006048266 A3 WO2006048266 A3 WO 2006048266A3
Authority
WO
WIPO (PCT)
Prior art keywords
leukemias
gene
mll
expression profiling
gene expression
Prior art date
Application number
PCT/EP2005/011732
Other languages
English (en)
Other versions
WO2006048266A2 (fr
Inventor
Torsten Haferlach
Martin Dugas
Wolfgang Kern
Alexander Kohlmann
Susanne Schnittger
Claudia Schoch
Original Assignee
Roche Diagnostics Gmbh
Hoffmann La Roche
Torsten Haferlach
Martin Dugas
Wolfgang Kern
Alexander Kohlmann
Susanne Schnittger
Claudia Schoch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh, Hoffmann La Roche, Torsten Haferlach, Martin Dugas, Wolfgang Kern, Alexander Kohlmann, Susanne Schnittger, Claudia Schoch filed Critical Roche Diagnostics Gmbh
Publication of WO2006048266A2 publication Critical patent/WO2006048266A2/fr
Publication of WO2006048266A3 publication Critical patent/WO2006048266A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des approches rapides et fiables de détection et de génotypage de leucémies. Plusieurs formes d'exécution concernent, par exemple, des procédés de génotypage de cellules de leucémies aiguës à t(11q23)/MLL. Outre ces procédés, l'invention concerne également des kits et des systèmes connexes.
PCT/EP2005/011732 2004-11-04 2005-11-03 Profil d'expression genetique de leucemies a rearrangements geniques mll WO2006048266A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62567304P 2004-11-04 2004-11-04
US60/625,673 2004-11-04

Publications (2)

Publication Number Publication Date
WO2006048266A2 WO2006048266A2 (fr) 2006-05-11
WO2006048266A3 true WO2006048266A3 (fr) 2006-08-24

Family

ID=36021847

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/011732 WO2006048266A2 (fr) 2004-11-04 2005-11-03 Profil d'expression genetique de leucemies a rearrangements geniques mll

Country Status (1)

Country Link
WO (1) WO2006048266A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383349B2 (en) 2007-03-16 2013-02-26 The Board Of Trustees Of The Leland Stanford Junior University Bone morphogenetic protein antagonist and uses thereof
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
WO2018145080A1 (fr) 2017-02-06 2018-08-09 Case Western Reserve University Compositions et procédés de modulation de l'activité de la déshydrogénase à chaîne courte
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (fr) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. Inhibiteurs de la kinase p38 réduisant l'expression du gène dux4 et des gènes aval pour le traitement de la fshd
CN109976760A (zh) * 2017-12-27 2019-07-05 北京东土科技股份有限公司 一种图形语言的交叉编译方法及交叉编译器

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002634A2 (fr) * 2000-06-30 2002-01-10 Incyte Genomics, Inc. Molécules de matrice extracellulaire et d'adhésion cellulaire
WO2002066954A2 (fr) * 2001-02-16 2002-08-29 Arbor Vita Corporation Interactions du domaine pdz et radeaux lipidiques
WO2003039443A2 (fr) * 2001-11-05 2003-05-15 Deutsches Krebsforschungszentrum Nouveaux marqueurs genetiques pour leucemies
WO2005043163A2 (fr) * 2003-11-04 2005-05-12 Roche Diagnostics Gmbh Methode pour distinguer des sous-types aml classes who

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002634A2 (fr) * 2000-06-30 2002-01-10 Incyte Genomics, Inc. Molécules de matrice extracellulaire et d'adhésion cellulaire
WO2002066954A2 (fr) * 2001-02-16 2002-08-29 Arbor Vita Corporation Interactions du domaine pdz et radeaux lipidiques
WO2003039443A2 (fr) * 2001-11-05 2003-05-15 Deutsches Krebsforschungszentrum Nouveaux marqueurs genetiques pour leucemies
WO2005043163A2 (fr) * 2003-11-04 2005-05-12 Roche Diagnostics Gmbh Methode pour distinguer des sous-types aml classes who

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HAFERLACH T ET AL: "The Diagnosis of 14 Specific Subtypes of Leukemia Is Possible Based on Gene Expression Profiles: A Study on 263 Patients with AML, ALL, CML, or CLL", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, vol. 100, no. 11, 16 November 2002 (2002-11-16), pages 139A, XP002263227, ISSN: 0006-4971 *
KOHLMANN A ET AL: "MOLECULAR CHARACTERIZATION OF ACUTE LEUKEMIAS BY USE OF MICROARRAY TECHNOLOGY", GENES, CHROMOSOMES & CANCER, vol. 37, no. 4, August 2003 (2003-08-01), pages 396 - 405, XP008025253 *
KOHLMANN A ET AL: "Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients.", LEUKEMIA : OFFICIAL JOURNAL OF THE LEUKEMIA SOCIETY OF AMERICA, LEUKEMIA RESEARCH FUND, U.K. JAN 2004, vol. 18, no. 1, January 2004 (2004-01-01), pages 63 - 71, XP002373717, ISSN: 0887-6924 *

Also Published As

Publication number Publication date
WO2006048266A2 (fr) 2006-05-11

Similar Documents

Publication Publication Date Title
WO2006089091A3 (fr) Procedes pour la detection de maladie residuelle minimale
EP1811023A4 (fr) Gene exprime specifiquement dans les cellules es et utilisation dudit gene
WO2008061104A3 (fr) Méthodes et trousses de détection de marqueurs du cancer de la prostate
WO2006028660A3 (fr) Gestion de puissance appelee a base de contexte
WO2008088595A3 (fr) Cellule photovoltaïque avec un polymère contenant des siloles
WO2006060646A3 (fr) Micro-reseau de cellules permettant de profiler des phenotypes cellulaires et une fonction genique
WO2007082154A3 (fr) Methode permettant de detecter un cancer a l'aide de b7-h1 et de b7-h4
WO2008033445A3 (fr) Accès sélectif à des parties d'un contenu numérique
WO2006048266A3 (fr) Profil d'expression genetique de leucemies a rearrangements geniques mll
WO2002077604A3 (fr) Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares
WO2010009000A8 (fr) Connecteurs rubans pour appareils de mesure
WO2008061213A3 (fr) Variations génétiques associées à des tumeurs
WO2006110613A3 (fr) Cellule d'electrolyse photovoltaique integree
WO2006010150A3 (fr) Gènes domestiques et méthodes d'identification desdits gènes
WO2007133625A3 (fr) Extraction d'information multilingue
GB2464049A (en) System for identifying content of digital data
TW200605845A (en) ECG electrode characterization and compensation
WO2009048530A3 (fr) Dosages à base de particules hautement multiplexées
WO2008067023A3 (fr) Cellule photovoltaïque avec polymère contenant du thiazole
WO2006015368A3 (fr) Molecules ayant en effet sur le developpement et la fonction cellulaire
WO2006119435A3 (fr) Procedes pour identifier des biomarqueurs de cancer et des proteines phosphorylees
WO2007076427A3 (fr) Cellules photovoltaïques en tandem
WO2009019319A3 (fr) Listes de cellules voisines
WO2007119065A3 (fr) Procédé et système informatique
TW200707459A (en) Identical chips with different operations in a system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05810753

Country of ref document: EP

Kind code of ref document: A2